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Abstract
Objective: Malignant otitis externa is a potentially life threatening infection of external auditory canal 
and skull base in an immunocompromised person. The outcome tends to be fatal due to the skull base 
osteomyelitis, especially if diagnois is delayed or is poorly treated. This epidemiological study in developing 
country is aimed at sensitizing for high level of suspicious early diagnosis and treatment.
Method: This is a prospective study of patients with diagnosis of malignant otitis externa managed in a 
tertiary hospital between year 2012 - 2016. All consented patients with the disorder were enrolled into the 
study. Data obtained were collated and analysed.
Result: Nine patients with malignant otitis externa were seen during the study period. Male to female ratio 
was 1:1. The peak was between 61 and 70 years. The most frequent symptoms were otalgia 9 (100%) 
and hearing loss 9 (100%) while cranial neuropathy was encountered in 6 (66.7%). The most implicated 
microganisms was Pseudomonas aeruginosa 7(28%). All patients had combination of both medical and 
surgical intervention. There was 1death (11.1%).
Conclusion: Malignant otitis external is a complication of diabetes with high morbidity, however prompt 
diagnosis and treatment could mitigate the mortality.
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Introduction 
Malignant otitis externa is a fatal, progressive and aggressive infection of the external auditory canal 
extending to the temporal bone and base of skull in immunocompromised individuals, elderly diabetes 
mellitus are often especially affected. There are microorganisms which could be responsible but 
infection with Pseudomonas aureginosa is the most common [1]. 
In 90% of cases, the disease involves Pseudomonas aureginosa infection in the elderly diabetic. 
Infrequently, it affects younger age groups who are immune compromised eg HIV, AIDS and 
malnutrition. The most common offending organisms is 95% Pseudomonas aeruginosa. Other 
infrequently incriminating bacterial are Staphylococcus aureus, Klebsiella spp and fungal eg Aspergillus 
species [2,3]. The infections begin in the external auditory canal and spread along the vascular and 
fascial planes, extending into the temporal bone through the external auditory canal osseocartilaginous 
junction or fissures of Santorini [4]. The infection causes bony erosion to involve intracranial structures 
which is the main cause of death. In addition to this, patients who are elderly and diabetics have 
innate defects in chemotaxis and phagocytosis of polymorphonuclear lymphocytes, monocytes, and 
macrophages which aid spread of the disease. The disease is staged based on extent of soft tissue 
and bony involvement or development of neurologic complications [5,6]. In stage l, the disease is 
limited to the external auditory canal, in stage ll there is extension to temporal bone with cranial 
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The data obtained were collated and entered into and 
analysed using SPSS version 18.
Results
A total of 9 patients presented with diagnosis of malignant 
otitis externa out of 10,014 patients seen during the study 
period. There were 5 male with 4 female with a Male to 
Female ratio of 1:1. The mean age of the study group was 64 
years. Table1. The peak age involvement was 61-70 years.
Diabetic mellitus was implicated in 8 (88.9%) while AIDS 
was found in 1 (11.1%)
Microbiological study of ear discharge and tissue biopsy 
from wound debridement culture and sensitivity revealed 
7(28%) Pseudomonas aureginosa. Staphylococcus aureus 
with Klebsiella sp were noted to account for 1(11.1%) each. 
This is shown in figure 1.
In our study of malignant otitis externa, 77.8% present with 
diseases of maximum duration of 8 week duration while 
it is more than 8 weeks in 22.2%. The findings on clinical 
history and examination were 100%of earache, and tender 
ear while least finding was 3(33.3%) of fever. Right ear was 
responsible for 66.7% while left ear was responsible for 
33.3% cases of the malignant otitis externa. We recorded 
100%cases of unilateral malignant otitis externa.As shown 
in figure 2. Malignant otitis externa affected 66.7% of right 
ear while 33.3% of left ear was noted but no bilateral ear 
was recorded.
Associated complications of malignant otitis externa were 
6 (66.7%) cranial nerve palsy as commonest, infratemporal 
and neck space abscess in 1 (11.1%) each. No associated 
complication in 2 (22.2%) of the patients studied. There was 
no mortality in any patient studied. As it was revealed in 
table 2.
nerve neuropathaties and, in stage lll, there is intracranial 
extension. Stage l has a good prognosis while stage lll is 
fatal at presentation.
The clinical features include: painful external ear canal 
and the ipsilateral jaw, purulent otorrhea usually offensive, 
hearing impairments, and occipital and temporal headache. 
There may be associated facial and pharyngeal symptoms in 
advanced cases. Clinical examination revealed tender pinna, 
edematous pinna including external auditory meatus and 
granulation polyps [7-9].
Diagnosis is made by high index of suspicion, 
microbiological culture of the organism and radiological 
investigations which include Computerised Tomography 
Scan (CT scan) and Magnetic Resonance Imaging(MRI). 
CT Scan is the investigation of choice as it delineates 
subtle changes in bone density and establishes the extent 
of soft tissue swelling. Radioisotope scans are also useful 
for monitoring treatment response, particularly Technetium 
99. Serial monitoring of CRP and ESR can help to evaluate 
response to the administered antibiotics.
The management includes meticulous aural toilet, antibiotics 
such as Ciprofloxacin or antifungal agent and blood glucose 
control in patients with diabetes [10-13]. Hyperbaric oxygen 
can be considered for cases with intracranial complication. 
Surgical management mostly limited to biopsy for microbial 
and histological diagnosis. Histologically, granulation 
tissue is characterized by non-specific inflammation with 
inflammatory cell infiltration and hyperplasia of squamous 
epithelium [14].
This prospective study is aimed at identify the possible 
complications, clinical manifestations, diagnosis, and 
management outcome of malignant otitis externa in our 
study population. 
Materials and Methods
This is a prospective hospital based study. The patients with 
a diagnosis of malignant otitis externa were seen over of 5 
years, January 2012 to December 2016.
The study was carried out in ear, nose and throat clinic of 
ENT Department of Ekiti state university teaching hospital 
located in south western part of Nigeria. This is one of the 
centre for management of diabetic mellitus.
Informed consent to be enrolled into this study was obtained 
from the patient or guardian before their enrollment into the 
study.
Interviewer assisted questionnaires were given to obtain 
information from the 9 patients or guardians. The data 
obtained were on biodata, presenting complaints, detailed 
ear, nose and throat history, past medical history, family and 
social history.
General physical examination to determine patient health 
status. Detail ear, nose and throat examination was performed 
to determine the extent of the disease.
Management information data were obtained and 
documented. These also includes detail data on requested 
investigations, medical and surgical treatment.
Age group/years Frequency/n
51-60
61-70
71-80
81-90
2
4
2
1
Total=9
Table 1: Age distribution of patients with malignant 
otitis externa
77.8% (7)
11.1% (1)
11.1% 
(1)
Pseudomonas aeruginosa Staphylococcus aureus Klebsiella sp
Figure 1: Bacteriology of malignant otitis externa
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All the patients had combination of both medical and 
surgical intervention.
Discussion
This rare fatal malignant otitis externa was found to be more 
common in males than females in previous research work. 
Same study revealed high mortality over a period 10 years 
of more than half of the studied patients [15]. Our study 
showed equal male to female proportion and mortality of 
less than 50% of the studied population. These findings may 
be due to high rate of suspicious of malignant otitis externa 
among diabetes mellitus patients at the study centre. 
Malignant otitis externa typically arises in patients who 
are immune suppressed. The most commonly affected 
immunosuppressed patients is diabetes mellitus in elderly 
patients. While it occurred in younger age patients who are 
AIDS, malnourished, or immune suppression from cancer 
and chemoradiotherapy [16,17]. Diabetes mellitus was 
responsible for 88.9%, majority of our cases of malignant 
otitis externa.
The most common implicated causative microorganisms 
is bacterial and Pseudomonas aeruginosa in about 90% of 
patients [17]. Pseudomonas aeruginosa account for (77.8%) 
of our studied population. This study revealed less commonly 
isolated causative organisms to be Staphylococcus and 
Aspergillus [18].
Malignant otitis externa start from external auditory canal 
and spread to base of skull with intracranial extension and 
neck extension leading to various complications [19-21]. 
Documented 
complications in previous studies includes osteomyelities, 
cranial nerve palsy, meningitis and brain abscess. In 
diabetes, factor such as microangiopathy, hypoperfusion 
and diminished host resistance contributes tremendously 
to these pathogenesis [22]. This work revealed absence of 
complication in 2 (22.2%) while facial nerve affectation 
occurred in 6 (66.6%).
Clinical presentation of malignant otitis externa are often 
present with an earache, ear discharge which does not respond 
to standard treatment regimes of ear toilet and antibiotic 
therapy [23-25]. This condition may also present with cranial 
nerve palsies, trismus when the pathology extended beyond the 
external auditory canal. All, 100% of our studied population 
presented with otalgia and this is similar to other documented 
findings in previous research [15].
In the early management of malignant otitis externa 
debridement and biopsy of the external auditory meat us 
with subsequent cultures and sensitivity were repeated 
during the early phase of our management as in previous 
study. Treatment for the disorder also requires initial 
hospitalisation for aggressive targeted antimicrobial therapy 
based on microscopy, cultureand sensitivity results. Our 
treatment régime includes combination of both surgical 
and medical therapy. The outcomes of treatment depend 
on the disease stage at presentation. Only 1 (11.1%) of our 
patients presented with stage lll. Our mortality record was 
1 (11.1%). Prompt diagnosis and antibiotic administration 
has improved our mortality and morbidity results. It is still 
alarming that mortality remains around 33% and increases to 
80% with cranial nerve involvement in previous findings15. 
However the predictor of complications includes skull base 
osteomyelitis, and multiple cranial nerves.
Conclusion
Malignant otitis externa remain uncommon pathology in 
otorhinollaryngological practice worldwide. Early diagnosis 
with prompt, timely and appropriate management will 
produce good outcome. It is therefore advised that diabetes 
patient with earache should be promptly referred by their 
managing physician.
Conflict of Intrest
The authors declared that there are no conflicts of intrest.
References
1. Chin RY, Nguyen TBV(2013) Synchronous Malignant Otitis 
Externa and Squamous Cell Carcinoma of the External 
Auditory Canal. Case Rep Otolaryngol 2013: 837169.
2. Hamzany Y, Soudry E, Preis M,  Hadar T, Hilly O et al. (2011) 
Fungal malignant external otitis. J Infect 62: 226–231.
3. Hollis S, Evans K (2011) Management of malignant 
(necrotising) otitis externa. J Laryngol Otol 2013: 1212–1217.
4. Carfrae MJ, Kesser BW (2008) Malignant otitis externa. 
Otolaryngologic Clinics of North America 41: 537–549.
5. Chen CN, Chen YS, Yeh TH, Hsu CJ, Tseng FY (2010) 
Outcomes of malignant external otitis: survival vs. mortality. 
Acta Otolaryngol 130: 89-94.
6. Soudry E, Hamzany Y, Preis M,  Joshua B, Hadar T et al. 
(2011) Malignant external otitis: analysis of severe cases. 
Otolaryngol Head Neck Surg 144: 758-762.
7. Blyth CC, Gomes L, Sorrell TC,  da Cruz M, Sud A et al. (2011) 
Skull-base osteomyelitis: fungal vs. bacterial infection. 
Clinical Microbiology and Infection 17: 306-311.
Frequency %
Earache
Headache
Otorrhea
Hearing loss
Tinnitus
Fever
Tenderear
Granulation tissue
Figure 2: Clinical features of patients with malignant 
otitis externa
Complication Number Percentage(%)
Nil
Cranial nerve palsy
Neck space abscess and 
gangrene
Infratemporal abscess
Septicemia
2
6
1
1
1
22.2
66.6
11.1
11.1
11.1
Table 2: Complication of malignant otitis externa
4Volume 1: Issue 1: 003
Citation: Adegbiji WA, Aremu SK, Nwawolo CC, Alabi SB, Lasisi AO (2017) Malignant Otitis Externa in Developing Country. Clin of 
Otorhinolaryngology (2017) 1:1 003
8. Mani N, Sudhoff H, Rajagopal S, Moffat D, Axon PR (2007) 
Cranial nerve involvement in malignant external otitis: 
implications for clinical outcome. The Laryngoscope 117: 
907-910.
9. Mak JC, Kim LH, Ong LTC, Bui TM (2010) Acute abducens 
nerve palsy and weight loss due to skull base osteomyelitis. 
Medical Journal of Australia 192: 719-720.
10. Walsh TJ, Anaissie EJ, Denning DW,  Herbrecht 
R, Kontoyiannis DP et al. (2008) Treatment of aspergillosis: 
clinical practice guidelines of the Infectious Diseases 
Society of America. Clin Infect Dis 46: 327-360.
11. Vourexakis Z, Kos MI, Guyot JP(2010) Atypical presentations 
of malignant otitis externa. J Laryngol Otol 124: 1205-1208.
12. Parize P, Chandesris MO, Lanternier F,  Poirée S, Viard JP 
et al. (2009) Antifungal therapy of Aspergillus invasive otitis 
externa: efficacy of voriconazole and review. Antimicrob 
Agents Chemother 53: 1048-1053.
13. Soudry E, Joshua BZ, Sulkes J, Nageris BI (2007) 
Characteristics and prognosis of malignant external otitis 
with facial paralysis. Arch Otolaryngol Head Neck Surg 
133:1002-1004.
14. Illing E, Zolotar M, Ross E, Olaleye O, Molony N et al. (2011) 
Malignant otitis externa with skull base. J Surg Case Rep 
2011: 6.
15. Lasisi OA, Nwaorgu OG (2001) Behavioural pattern of 
malignant otitis external: 10-year review in Ibadan. Afr J 
Med Med Sci 30: 221-223.
16. Grandis JR, Branstetter BF, IV, Yu VL (2004). The changing 
face of malignant (necrotising) external otitis: clinical, 
radiological, and anatomic correlations. Lancet Infectious 
Diseases 4: 34-39.
17. Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet 
V(2007) Necrotizing external otitis: a report of 46 cases. 
Otology and Neurotology 28: 771-773.
18. ClarkJH, LinFR, Salaria SN,  Stewart CM, Francis HW (2011) 
Malignant Otitis Externa caused by Aspergillus fumigatus: A 
Case Report. Otology Neurotology 32: e22–23.
19. Sreepada GS, Kwartler JA (2003) Skull base osteomyelitis 
secondary to malignant otitis externa. Curr Opin 
Otolaryngol Head Neck Surg 11: 316-23.
20. Snow JB, Ballenger JJ (2003) Ballenger’s Otorhinolaryngology 
Head and Neck Surgery. Ontario: BC Decker.
21. Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet 
V (2007) Necrotizing external otitis: a report of 46 cases. 
Otology and Neurotology 28: 771-773. 
22. Singh A, Al Khabori M, Hyder J (2005) Skull Base 
Osteomyelitis: Diagnosis and Therapeutic Challenges in 
Atypical Presentation. Otolaryngology – Head and Neck 
Surgery 133: 121-125.
23. Joshua BZ, Sulkes J, Raveh E, Bishara J, Nageris BI (2008) 
Predicting outcome of malignant external otitis. Otology & 
Neurotology 29: 339-343.
24. Thio D, Reece P, Herdman R(2008) Necrotizing otitis 
externa: a painless reminder. European Archives of Oto-
Rhino-Laryngology 265: 907-910.
25. Rutka J (2004) Acute otitis externa: treatment perspectives. 
Ear Nose Throat J 83: 20-21.
